First vaccine approved by FDA to prevent serogroup B Meningococcal disease

The U.S. Food and Drug Administration announced today the approval of Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Meningococcal disease is a…

Source:First vaccine approved by FDA to prevent serogroup B Meningococcal disease